SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2.16 |
| Enterprise Value ($M) | -3.23 |
| Book Value ($M) | 4.95 |
| Book Value / Share | 5.75 |
| Price / Book | 0.44 |
| NCAV ($M) | 4.95 |
| NCAV / Share | 5.75 |
| Price / NCAV | 0.44 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.50 |
| Return on Assets (ROA) | -0.78 |
| Return on Equity (ROE) | -1.03 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.38 |
| Current Ratio | 6.38 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 5.86 |
| Assets | 5.87 |
| Liabilities | 0.92 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Intracoastal Capital, Llc | 4.99 | -94.93 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 13,807 | 41,358 | 33.38 | |
| 5,080 | 8,253 | 61.55 | |
| 12,099 | 34,323 | 35.25 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PALI – Palisade Bio, Inc. | PCSA – Processa Pharmaceuticals, Inc. |
| PDSB – PDS Biotechnology Corporation | PIRS – Pieris Pharmaceuticals, Inc. |
| PLUR – Pluri Inc. |
Financial data and stock pages provided by
Fintel.io